137
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Dynamic regulatory network controlling Th17 cell differentiation

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Despite their importance, the molecular circuits that control the differentiation of naïve T cells remain largely unknown. Recent studies that reconstructed regulatory networks in mammalian cells have focused on short-term responses and relied on perturbation-based approaches that cannot be readily applied to primary T cells. Here, we combine transcriptional profiling at high temporal resolution, novel computational algorithms, and innovative nanowire-based tools for performing perturbations in primary T cells to systematically derive and experimentally validate a model of the dynamic regulatory network that controls Th17 differentiation. The network consists of two self-reinforcing, but mutually antagonistic, modules, with 12 novel regulators, whose coupled action may be essential for maintaining the balance between Th17 and other CD4+ T cell subsets. Overall, our study identifies and validates 39 regulatory factors, embeds them within a comprehensive temporal network and reveals its organizational principles, and highlights novel drug targets for controlling Th17 differentiation.

          Related collections

          Most cited references40

          • Record: found
          • Abstract: found
          • Article: not found

          Direct multiplexed measurement of gene expression with color-coded probe pairs.

          We describe a technology, the NanoString nCounter gene expression system, which captures and counts individual mRNA transcripts. Advantages over existing platforms include direct measurement of mRNA expression levels without enzymatic reactions or bias, sensitivity coupled with high multiplex capability, and digital readout. Experiments performed on 509 human genes yielded a replicate correlation coefficient of 0.999, a detection limit between 0.1 fM and 0.5 fM, and a linear dynamic range of over 500-fold. Comparison of the NanoString nCounter gene expression system with microarrays and TaqMan PCR demonstrated that the nCounter system is more sensitive than microarrays and similar in sensitivity to real-time PCR. Finally, a comparison of transcript levels for 21 genes across seven samples measured by the nCounter system and SYBR Green real-time PCR demonstrated similar patterns of gene expression at all transcript levels.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells.

            On activation, naive T cells differentiate into effector T-cell subsets with specific cytokine phenotypes and specialized effector functions. Recently a subset of T cells, distinct from T helper (T(H))1 and T(H)2 cells, producing interleukin (IL)-17 (T(H)17) was defined and seems to have a crucial role in mediating autoimmunity and inducing tissue inflammation. We and others have shown that transforming growth factor (TGF)-beta and IL-6 together induce the differentiation of T(H)17 cells, in which IL-6 has a pivotal function in dictating whether T cells differentiate into Foxp3+ regulatory T cells (T(reg) cells) or T(H)17 cells. Whereas TGF-beta induces Foxp3 and generates T(reg) cells, IL-6 inhibits the generation of T(reg) cells and induces the production of IL-17, suggesting a reciprocal developmental pathway for T(H)17 and T(reg) cells. Here we show that IL-6-deficient (Il6-/-) mice do not develop a T(H)17 response and their peripheral repertoire is dominated by Foxp3+ T(reg) cells. However, deletion of T(reg) cells leads to the reappearance of T(H)17 cells in Il6-/- mice, suggesting an additional pathway by which T(H)17 cells might be generated in vivo. We show that an IL-2 cytokine family member, IL-21, cooperates with TGF-beta to induce T(H)17 cells in naive Il6-/- T cells and that IL-21-receptor-deficient T cells are defective in generating a T(H)17 response.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              T(H)-17 cells in the circle of immunity and autoimmunity.

              CD4(+) effector T cells have been categorized into two subsets: T helper type 1 (T(H)1) and T(H)2. Another subset of T cells that produce interleukin 17 (IL-17; 'T(H)-17 cells') has been identified that is highly proinflammatory and induces severe autoimmunity. Whereas IL-23 serves to expand previously differentiated T(H)-17 cell populations, IL-6 and transforming growth factor-beta (TGF-beta) induce the differentiation of T(H)-17 cells from naive precursors. These data suggest a dichotomy between CD4(+) regulatory T cells positive for the transcription factor Foxp3 and T(H)-17 cells: TGF-beta induces Foxp3 and generates induced regulatory T cells, whereas IL-6 inhibits TGF-beta-driven Foxp3 expression and together with TGF-beta induces T(H)-17 cells. Emerging data regarding T(H)-17 cells suggest a very important function for this T cell subset in immunity and disease.
                Bookmark

                Author and article information

                Journal
                0410462
                6011
                Nature
                Nature
                Nature
                0028-0836
                1476-4687
                7 March 2013
                06 March 2013
                25 April 2013
                25 October 2013
                : 496
                : 7446
                : 461-468
                Affiliations
                [1 ]Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA
                [2 ]Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
                [3 ]Departments of Chemistry and Chemical Biology and of Physics, Harvard University, Cambridge, MA
                [5 ]Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA
                [6 ]Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT
                [7 ]University of Oxford, Headington Campus, Oxford, United Kingdom
                [8 ]Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN
                Author notes
                [§ ] To whom correspondence should be addressed: aregev@ 123456broad.mit.edu (AR), vkuchroo@ 123456rics.bwh.harvard.edu (VK), Hongkun_Park@ 123456harvard.edu (HP)
                [*]

                These authors contributed equally to this work

                [4]

                Present address: Translational Health Science & Technology Institute, Faridabad, Haryana, India

                Article
                NIHMS442948
                10.1038/nature11981
                3637864
                23467089
                6e90bdee-ce5b-4c87-a1b5-24a89ebbd797

                Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Funding
                Funded by: National Institute of Neurological Disorders and Stroke : NINDS
                Award ID: R01 NS045937 || NS
                Funded by: National Institute of Neurological Disorders and Stroke : NINDS
                Award ID: R01 NS030843 || NS
                Funded by: National Human Genome Research Institute : NHGRI
                Award ID: P50 HG006193 || HG
                Funded by: National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID
                Award ID: P01 AI073748 || AI
                Funded by: National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID
                Award ID: P01 AI045757 || AI
                Funded by: Office of the Director : NIH
                Award ID: DP1 OD003958 || OD
                Funded by: Office of the Director : NIH
                Award ID: DP1 OD003893 || OD
                Categories
                Article

                Uncategorized
                Uncategorized

                Comments

                Comment on this article